Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: Role of sigma-1 receptors

References

Page 1

	Year	Citations
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β Toshiyuki Nakagawa, Hong Zhu, Nobuhiro Morishima, Nature ApoptosisCell DeathDegenerative PathologyCellular BiochemistryMedicine	2000	3.2K
Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival Teruo Hayashi, Tsung‐Ping Su Cell Signal TransductionMitochondrial FunctionOrganelle DynamicNatural SciencesMitochondrial Dynamic	2007	1.7K
Glutamate Receptor Dysfunction and Schizophrenia John W. Olney Archives of General Psychiatry	1995	1.7K
Decreased Serum Levels of D-Serine in Patients With Schizophrenia Kenji Hashimoto, Takeshi Fukushima, Eiji Shimizu, Archives of General Psychiatry	2003	484
The anti‐amnesic and neuroprotective effects of donepezil against amyloid β<sub>25‐35</sub>peptide‐induced toxicity in mice involve an interaction with the<i>σ</i><sub>1</sub>receptor Johann Meunier, John R. Ieni, Tangui Maurice British Journal of Pharmacology	2006	281
Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain Natsuko Narita, Kenji Hashimoto, Shinichiro Tomitaka, European Journal of Pharmacology NeurophysiologyMedicineNeurotransmitterSelective SerotoninPsychopharmacology	1996	253
NMDA Agonists and Antagonists as Probes of Glutamatergic Dysfunction and Pharmacotherapies in Neuropsychiatric Disorders John H. Krystal, Cyril D’Souza, Ismene L. Petrakis, Harvard Review of Psychiatry NeuropsychologyNeuropsychiatric DisordersPsychotropic MedicationPsychopharmacologyNeuropsychiatry	1999	229
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia Joseph I. Friedman, David N Adler, Evelyn Howanitz, Biological Psychiatry NeuropsychologyPsychiatryPsychotic DisorderPsychotropic MedicationCognitive Dysfunction	2002	170
Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia Arthur D. Weissman, Manuel F. Casanova, Joel E. Kleinman, Biological Psychiatry Neuroimaging BiomarkersPsychiatrySelective LossSchizophreniaNeuropsychiatry	1991	149
Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial Richard S.E. Keefe, Anil K. Malhotra, Herbert Y. Meltzer, Neuropsychopharmacology Significant Placebo/practice EffectsPsychiatryPsychotic DisorderPharmacologyPsychopharmacology	2007	147

Page 1